Key points
- Sales Revenue up 17% YoY, ARR up 12% YoY
- Underlying EBITDA improved by 11%
- Eight proprietary AI agents launched
- New CFO and Company Secretary appointed
Full summary
IMEXHS Ltd presented its H1 FY26 results, highlighting a 17% year-over-year (YoY) increase in sales revenue to $16.0 million and a 12% YoY increase in Annual Recurring Revenue (ARR) to $36.8 million. Underlying EBITDA improved by 11% to $2.0 million. The company launched eight proprietary AI agents across its radiology workflow, enhancing operational efficiency. IMEXHS also announced the appointment of Mr. Fabio Carrillo as the new Chief Financial Officer and Ms. Kamille Dietrich as the Company Secretary. The company expects revenue for FY26 to be in the range of $31.4 million to $33.7 million and underlying EBITDA to be in the range of $2.4 million to $2.7 million.
Guidance
FY26 Revenue: $31.4m to $33.7m, Underlying EBITDA: $2.4m to $2.7m
Outlook
IMEXHS Ltd expects to achieve revenue and underlying EBITDA guidance for FY26, with a focus on converting large-deal capability into repeatable performance and improving service quality.